Intuitive Surgical, Inc.

NASDAQ:ISRG

537.07 (USD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998
Revenue 7,124.16,222.25,710.14,358.44,478.53,724.23,128.92,704.42,384.42,131.72,265.12,178.81,757.31,4131,052.168874.919600.828372.682227.338138.80391.67572.02251.67326.62410.1920
Cost of Revenue 2,394.62,026.21,751.61,497.21,368.31,120.1934.8814.3806.5717.9670.9608.5483.5383301.116254.142186.542124.84673.76950.81347.64634.58428.21813.2797.030
Gross Profit 4,729.54,1963,958.52,861.23,110.22,604.12,194.11,890.11,577.91,413.81,594.21,570.31,273.81,030751.052620.777414.286247.836153.56987.9944.02937.43823.45513.3453.1620
Gross Profit Ratio 0.6640.6740.6930.6560.6940.6990.7010.6990.6620.6630.7040.7210.7250.7290.7140.710.690.6650.6760.6340.480.520.4540.5010.310
Reseach & Development Expenses 998.8879671595.1557.3418.1328.6239.6197.4178167.7170140.211695.10279.37248.85929.77817.35417.81216.1916.79313.85111.73411.1323.208
General & Administrative Expenses 00000986.6810.9705.3640.5691574522.2438.8358.8278.511230.57158.685110.70367.44348.99439.71940.86429.98719.13600
Selling & Marketing Expenses 00000000000000000000000000
SG&A 1,963.91,739.91,466.51,216.31,178.4986.6810.9705.3640.5691574522.2438.8358.8278.511230.57158.685110.70367.44348.99439.71940.86429.98719.1369.3387.565
Other Expenses 000000000000000000000004.75211.5817.565
Operating Expenses 2,962.72,618.92,137.51,811.41,735.71,404.71,139.5944.9837.9869741.7692.2579474.8373.613309.942207.544140.48184.79766.80655.90957.65743.83835.62222.71130.773
Operating Income 1,766.81,211.31,821773.61,374.51,199.41,054.6945.2740544.8852.5878.1694.8555.2377.439310.835206.742107.35568.77221.184-11.88-20.219-20.383-22.277-19.549-30.773
Operating Income Ratio 0.2480.1950.3190.1770.3070.3220.3370.350.310.2560.3760.4030.3950.3930.3590.3550.3440.2880.3030.153-0.13-0.281-0.394-0.837-1.9180
Total Other Income Expenses Net 192.1395.569.3433.4127.780.141.935.618.54.218.415.814.917.118.67224.36830.49212.783-0.5170.2420.394-0.0430.042-0.10800
Income Before Tax 1,958.91,606.81,890.31,2071,502.21,279.51,096.5980.8758.5549870.9893.9709.7572.3396.111335.203237.234120.13873.80724.204-9.623-18.421-20.341-22.38500
Income Before Tax Ratio 0.2750.2580.3310.2770.3350.3440.350.3630.3180.2580.3840.410.4040.4050.3760.3830.3950.3220.3250.174-0.105-0.256-0.394-0.84100
Income Tax Expense 141.6262.4162.2140.2120.4154.5436.5244.9169.7130.2199.9237.3214.6190.5163.505130.88892.69748.094-20.3270.726-2.257-1.798-3.683-3.754-1.13429.443
Net Income 1,7981,322.31,704.61,060.61,379.31,127.9660735.9588.8418.8671656.6495.1381.8232.606204.315144.53772.04494.13423.478-9.623-18.421-16.7-18.523-18.415-29.443
Net Income Ratio 0.2520.2130.2990.2430.3080.3030.2110.2720.2470.1960.2960.3010.2820.270.2210.2340.2410.1930.4140.169-0.105-0.256-0.323-0.696-1.8070
EPS 5.123.724.793.023.983.311.972.131.761.261.861.831.41.080.670.580.420.220.30.078-0.045-0.11-0.1-0.17-0.85-1.81
EPS Diluted 5.033.654.662.943.853.161.892.081.731.231.861.781.371.050.660.570.410.210.280.074-0.045-0.11-0.1-0.17-0.85-1.81
EBITDA 1,766.81,577.11,8211,049.81,374.51,199.41,054.6945.2740544.8852.5878.1694.8555.2377.439335.919219.769142.62476.01628.053-1.645-15.627-15.713-17.417-17.306-30.773
EBITDA Ratio 0.2480.2530.3190.2410.3070.3220.3370.350.310.2560.3760.4030.3950.3930.3590.3840.3660.3830.3340.202-0.018-0.217-0.304-0.654-1.6980